Your browser doesn't support javascript.
loading
Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Yokota, Chisato; Kagawa, Naoki; Takano, Koji; Chiba, Yasuyoshi; Kinoshita, Manabu; Kijima, Noriyuki; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo; Tsuboi, Akihiro; Izumoto, Shuichi; Kishima, Haruhiko; Hashimoto, Naoya.
Afiliação
  • Yokota C; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Kagawa N; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan. nkagawa@nsurg.med.osaka-u.ac.jp.
  • Takano K; Department of Neurosurgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan.
  • Chiba Y; Department of Neurosurgery, Osaka Women's and Children's Hospital, 840, Murodo-choIzumi, Osaka, 594-1101, Japan.
  • Kinoshita M; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Kijima N; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Oji Y; Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Oka Y; Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Sugiyama H; Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Tsuboi A; Department of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Izumoto S; Cancer Immunology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Kishima H; Cancer Immunotherapy, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Hashimoto N; Department of Neurosurgery, Kindai University Nara Hospital, 1248-1, Otsuda-cho, Ikoma city, Nara, 630-0293, Japan.
Cancer Immunol Immunother ; 71(1): 189-201, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34089373
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Regulação Neoplásica da Expressão Gênica / Proteínas WT1 / Glioma / Imunoterapia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Regulação Neoplásica da Expressão Gênica / Proteínas WT1 / Glioma / Imunoterapia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão